Shawn S. Yu

发表

A Graphical Classification of Survival Distributions

Shawn S. Yu, Eberhard O. Vorr, 1996 .

Comparing Pioglitazone to Insulin with Respect to Cancer, Cardiovascular and Bone Fracture Endpoints, Using Propensity Score Weights

Carlos Vallarino, Shawn Yu, Alfonso T. Perez, 2013, Clinical Drug Investigation.

A comparison of all-cause mortality with pioglitazone and insulin in type 2 diabetes: an expanded analysis from a retrospective cohort study

Alfonso T. Perez, Huifang Liang, Shawn S. Yu, 2014, Current medical research and opinion.

Original article A comparison of all-cause mortality with pioglitazone and insulin in type 2 diabetes: an expanded analysis from a retrospective cohort study

Huifang Liang, Shawn S. Yu, C. Vallarino, 2014 .

Treatment of Osteoarthritis with a Once‐Daily Dosing Regimen of Celecoxib: A Randomized, Controlled Trial

Gary W. Williams, E. Ruderman, R. Hubbard, 2000, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Effects of Celecoxib, a Novel Cyclooxygenase‐2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled Trial

P. Isakson, R. Hubbard, A. Karim, 2000, Journal of clinical pharmacology.

Mo1834 Clinical Characteristics of Crohn's Disease or Ulcerative Colitis Patients Who Initiated Vedolizumab or an anti-TNF-α As First Biologic Therapy

Huifang Liang, Shawn S. Yu, P. Dolin, 2016 .

Evaluation of the Functional Status Aspects of Health‐Related Quality of Life of Patients with Osteoarthritis Treated with Celecoxib

S. Z. Zhao, S. Dedhiya, J. Osterhaus, 1999, Pharmacotherapy.

Uncovering the Blind Spot of Clinical Trials: First Report of Baseline Characteristics of Newly Diagnosed (ND) and Relapsed/Refractory (RR) Multiple Myeloma (MM) Patients (Pts) in Insight-MM, a Global, Prospective, Observational Study

H. Goldschmidt, M. Boccadoro, R. Hájek, 2017 .

A Global Treatment Standard in Multiple Myeloma (MM) Remains Elusive Despite Advances in Care over 15 years: First Results from INSIGHT MM, the Largest Global Prospective, Observational MM Study: MM‐230

H. Goldschmidt, N. Puig, M. Boccadoro, 2018, Clinical Lymphoma Myeloma and Leukemia.

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.

D. Graham, P. Lipsky, P. Isakson, 1999, JAMA.

Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.

P. Isakson, J. Fiechtner, R. Hubbard, 1999, Mayo Clinic proceedings.